A Pilot Phase IIB, Randomized, Multi-Center Trial of Argatroban in Combination with Recombinant Tissue Plasminogen Activator for Acute Stroke (ARTSS-2)

Grant

Total Award Amount

  • 31794.00
  • Direct Costs

  • 21702.00
  • Sponsor Award Id

  • Contributor

  • Angela Hays Shapshak   Principal Investigator  
  • Louis Nabors M.D.   Investigator